Akarca F, Shaheen N, Stachler M
BMJ Oncol. 2025; 2(1):e000089.
PMID: 39886511
PMC: 11203143.
DOI: 10.1136/bmjonc-2023-000089.
Davies E
Cancer Med. 2025; 14(2):e70607.
PMID: 39812114
PMC: 11733675.
DOI: 10.1002/cam4.70607.
Laun S, Pierre F, Kim S, Lunz D, Maddala T, Braun J
Diagnostics (Basel). 2024; 14(18).
PMID: 39335682
PMC: 11431466.
DOI: 10.3390/diagnostics14182003.
Noordzij I, Huysentruyt C, Curvers W, van Lijnschoten G, Masclee A, Schoon E
Endoscopy. 2024; 56(12):906-912.
PMID: 39313196
PMC: 11716541.
DOI: 10.1055/a-2386-7843.
Rosmolen W, Pouw R, Bergman J, Sprangers M, Nieuwkerk P
Dis Esophagus. 2024; 37(12).
PMID: 39169835
PMC: 11605615.
DOI: 10.1093/dote/doae067.
Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients with Barrett's Esophagus.
Laun S, Kann L, Braun J, Gilbert S, Lunz D, Pierre F
Am J Gastroenterol. 2024; .
PMID: 39140473
PMC: 11825890.
DOI: 10.14309/ajg.0000000000003030.
Improving esophageal cancer screening across the globe: Translating knowledge into action.
Sachdeva K, Natarajan K, Iyer P
Indian J Gastroenterol. 2024; 43(4):705-716.
PMID: 38848004
PMC: 11345747.
DOI: 10.1007/s12664-024-01543-z.
Risk stratification for synchronous/metachronous recurrence after endoscopic submucosal dissection for Barrett's esophageal adenocarcinoma using the length of Barrett's esophagus.
Ikenoyama Y, Namikawa K, Takamatsu M, Kumazawa Y, Tokai Y, Yoshimizu S
Esophagus. 2024; 21(3):357-364.
PMID: 38607537
DOI: 10.1007/s10388-024-01058-8.
Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study.
Byrne C, Brennan P, Carberry J, Cotton J, Dillon J
BMJ Open Gastroenterol. 2024; 11(1).
PMID: 38519048
PMC: 10966788.
DOI: 10.1136/bmjgast-2023-001307.
A Comprehensive Analysis of Tn and STn Antigen Expression in Esophageal Adenocarcinoma.
Mercanoglu B, Karstens K, Giannou A, Meiners J, Lucke J, Seeger P
Cancers (Basel). 2024; 16(2).
PMID: 38254730
PMC: 10814236.
DOI: 10.3390/cancers16020240.
Endoscope Capsules: The Present Situation and Future Outlooks.
Gounella R, Granado T, Hideo Ando Junior O, Luporini D, Gazziro M, Carmo J
Bioengineering (Basel). 2023; 10(12).
PMID: 38135938
PMC: 10741108.
DOI: 10.3390/bioengineering10121347.
Causal association between dietary factors and esophageal diseases: A Mendelian randomization study.
Zou M, Liang Q, Zhang W, Zhu Y, Xu Y
PLoS One. 2023; 18(11):e0292113.
PMID: 38019753
PMC: 10686502.
DOI: 10.1371/journal.pone.0292113.
Are patients with eosinophilic esophagitis treated at an academic hospital comparable to a patient from a population-based cohort? Not in Denmark.
Melgaard D, Andersen I, Frandsen L, Mortensen C, Hansen L, Krarup A
JGH Open. 2023; 7(8):572-578.
PMID: 37649862
PMC: 10463017.
DOI: 10.1002/jgh3.12952.
Wirelessly powered deformable electronic stent for noninvasive electrical stimulation of lower esophageal sphincter.
Zhang C, Pan C, Chan K, Gao J, Yang Z, Leung K
Sci Adv. 2023; 9(10):eade8622.
PMID: 36888700
PMC: 9995080.
DOI: 10.1126/sciadv.ade8622.
Usefulness of the Japan Esophageal Society Classification of Barrett's Esophagus for Diagnosing the Lateral Extent of Superficial Short-Segment Barrett's Esophageal Cancer.
Suzuki Y, Okamura T, Matsui A, Hayasaka J, Nomura K, Kikuchi D
Gastrointest Tumors. 2023; 9(2-4):59-68.
PMID: 36590852
PMC: 9801400.
DOI: 10.1159/000525586.
The utility of a genetic progression risk test for Barrett esophagus.
Gong D, Lunz D, Stover J, Meltzer S
Medicine (Baltimore). 2022; 101(37):e30503.
PMID: 36123898
PMC: 10662832.
DOI: 10.1097/MD.0000000000030503.
Barrett's Esophagus in Obese Patient Post-Roux-en-Y Gastric Bypass: a Systematic Review.
Qumseya B, Qumsiyeh Y, Sarheed A, Rosasco R, Qumseya A
Obes Surg. 2022; 32(11):3513-3522.
PMID: 36114989
DOI: 10.1007/s11695-022-06272-w.
Endoscopic Management of Esophageal Cancer.
Paiji C, Sedarat A
Cancers (Basel). 2022; 14(15).
PMID: 35892840
PMC: 9329770.
DOI: 10.3390/cancers14153583.
Surveillance of Barrett's esophagus using wide-area transepithelial sampling: systematic review and meta-analysis.
Qumseya B, Bukannan A, Rosasco R, Liu X, Qumseya A
Endosc Int Open. 2022; 10(4):E394-E402.
PMID: 35433217
PMC: 9010089.
DOI: 10.1055/a-1783-9015.
The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia.
Januszewicz W, Pilonis N, Sawas T, Phillips R, ODonovan M, Miremadi A
Histopathology. 2022; 80(7):1081-1090.
PMID: 35274753
PMC: 9321087.
DOI: 10.1111/his.14642.